Overview of Dr. Faltas
Dr. Bishoy Faltas is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Assiut Faculty of Medicine and has been in practice 12 years. He is one of 379 doctors at New York-Presbyterian Hospital and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
520 E 70th St
# Starr
New York, NY 10021Fax+1 646-962-1603
Education & Training
- New York-Presbyterian HospitalPost-Doctoral Fellowship, 2015 - 2016
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2012 - 2015
- Rochester General HospitalResidency, Internal Medicine, 2006 - 2009
- University of Assiut Faculty of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2009 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCI-YPSA Young Physician-Scientist Awards The American Society for Clinical Investigation, 2022
- NextGen Star American Association for Cancer Research (AACR), 2017
- Finalist, 2nd place for best research presentation Immuno-oncology Young Investigators’ forum, 2016
- Join now to see all
Clinical Trials
- (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer Start of enrollment: 2019 Feb 05
Publications & Presentations
PubMed
- 605 citationsPersonalized In Vitro and In Vivo Cancer Models to Guide Precision MedicineChantal Pauli, Benjamin D. Hopkins, Davide Prandi, Reid Shaw, Tarcisio Fedrizzi
Cancer Discovery. 2017-05-01 - 1594 citationsPan-cancer analysis of whole genomesPeter J. Campbell, Gad Getz, Jan O. Korbel, Joshua M. Stuart, Jennifer L. Jennings
Nature. 2020-02-06 - 140 citationsUpper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signalingBrian D. Robinson, Panagiotis J. Vlachostergios, Bhavneet Bhinder, Weisi Liu, Kailyn Li
Nature Communications. 2019-07-05
Journal Articles
- Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J,..., JAMA Oncol
- Perioperative Bridging Anticoagulation in Patients with Atrial FibrillationDouketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE ..., N Engl J Med, 1/1/2015
- A Precision Medicine Trial for Whole Exome Sequencing of Metastatic Cancer Reveals Biomarkers of Treatment ResponseBeltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J,..., JAMA Oncol, 1/1/2015
- Join now to see all
Abstracts/Posters
- Whole exome sequencing reveals 19q13 amplification and actionable mutations in carcinosarcoma of the bladder.Peyman Tavassoli, Bishoy Faltas, Joanna Cyrta, Juan Miguel Mosquera, Brian D Robinson, Mark Rubin, United States & Canadian Academy of Pathology (USCAP) Meeting, 1/1/2016
- Integrated whole exome and RNA sequencing reveals distinct genomic and transcriptomic landscape of upper tract urothelial carcinoma.Bishoy Faltas, Rohan Bareja, Himisha Beltran, Joanna Cyrta, Manoj P. Rai, Scott T. Tagawa, David Nanus, Juan Miguel Mosquera, Andrea Sboner, Douglas Scherr, Olivier El..., American Society of Clinical Oncology Genitourinary Symposium (ASCO-GU), 1/1/2016
- Treatment for metastatic platinum-resistant urothelial cancer (PRUC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): phase I...Scott T. Tagawa, Bishoy Faltas, Elaine Lam, Wells A. Messersmith, Philip Saylor, Aditya Bardia, Julio J. Hajdenberg, Alicia K. Morgans, Jordan D. Berlin, Emerson Lim, ..., American Association for Cancer research (AACR) annual meeting, 1/1/2016
- Join now to see all
Lectures
- Generating a neoantigen map of advanced urothelial carcinoma by whole exome sequencing.1/1/2016
- Clonal heterogeneity in platinum-resistant metastatic urothelial cancer.1/1/2015
Other
- Making new medicines- How next generation sequencing is transforming drug-development.Faltas B, Bitesizebio
1/18/2013 - Never a Dull Moment: A Day in the Life of an Oncology Fellow.Faltas B, ASCO Post
1/15/2013 - The Nuts and Bolts of Getting into an Oncology FellowshipFaltas B, ASCO Post
1/15/2012 - Join now to see all
Press Mentions
- Oncologist Receives Prestigious MERIT Grant from the National Cancer Institute for Bladder Cancer ResearchMarch 1st, 2024
- Cancer Projects to Diversify Genetic Research Receive New GrantsSeptember 11th, 2020
- Mutations, DNA Structures Linked to Bladder CancerOctober 12th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Member
External Links
- Dr. Faltashttps://www.youtube.com/watch?v=nVz3alUpH3k
- Conqueror in Actionhttps://www.youtube.com/watch?v=GYVwrzEtdvw
- Lab websitehttps://faltaslab.weill.cornell.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: